These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 7480962)

  • 1. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is routine monitoring of theophylline blood levels really effective?].
    Atsmon J; Priel IE; Dolev E
    Harefuah; 1995 Nov; 129(9):304-8, 368. PubMed ID: 8549976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
    Chuchalin AG; Tsoĭ AN; Zaĭtseva TM; Titova EV; Medani SM; Smirnov MV; Kaziakhmedov EA
    Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.
    Oren R; Beeri M; Hubert A; Kramer MR; Matzner Y
    Arch Intern Med; 1997 Jul; 157(13):1474-8. PubMed ID: 9224226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic activities of theophylline in chronic obstructive pulmonary disease.
    Peleman RA; Kips JC; Pauwels RA
    Clin Exp Allergy; 1998 Aug; 28 Suppl 3():53-6. PubMed ID: 9756187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 13. [The hemodynamic effects of reproterol in patients with chronic obstructive lung disease (author's transl)].
    Bonaduce D; Ferrara N; Canonico V; Cocozza M; Petretta M; Romano E; Rengo F
    G Ital Cardiol; 1981; 11(10):1467-71. PubMed ID: 7341317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral doxofylline on inflammatory changes and altered cell proliferation in chronic obstructive bronchitis.
    Cogo R; Castronuovo A
    Eur Rev Med Pharmacol Sci; 2000; 4(1-2):15-20. PubMed ID: 11409184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bronchospasmolytic effectiveness of controlled drug combinations].
    Forche G; Zenker G; Harnoncourt K
    Wien Med Wochenschr; 1986 May; 136(9):213-8. PubMed ID: 3739357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutical effect of a new antidyspnoeic drug in the chronic obstructive pulmonary disease (author's transl)].
    Chillón F
    Folia Clin Int (Barc); 1973 Jun; 23(6):464-76. PubMed ID: 4805350
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravenous therapy of chronic obstructive pulmonary disease with sodium glycinate theophylline monitored by a new bed side theophylline assay.
    Knöbl PN; Burghuber OC
    Acta Med Austriaca; 1992; 19(4):114-7. PubMed ID: 1290320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ranitidine on the pharmacokinetics of theophylline in patients with obstructive pulmonary disease].
    Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V; Bozović M
    Glas Srp Akad Nauka Med; 1991; (41):45-52. PubMed ID: 1916446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced serum theophylline concentrations after discontinuation of azithromycin: evidence for an unusual interaction.
    Pollak PT; Slayter KL
    Pharmacotherapy; 1997; 17(4):827-9. PubMed ID: 9250566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of theophylline in 'irreversible' chronic obstructive pulmonary disease. An update.
    Hill NS
    Arch Intern Med; 1988 Dec; 148(12):2579-84. PubMed ID: 3058071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.